|

Oral Paclitaxel Solution Clinical Trials

1 actively recruiting trial

Also known as: DHP107, Liporaxel, Oral paclitaxel

Pipeline

Phase 4: 1

Top Sponsors

  • Shanghai Pulmonary Hospital, Shanghai, China1

Indications

Other1 trial

Oral Paclitaxel Solution With Immunotherapy and Concurrent SBRT as Neoadjuvant Treatment for Older Adults With NSCLC
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.